Skip to main content
Clinical Trials/NCT02474433
NCT02474433UnknownPhase 4

Same-day Cervical Preparation With Misoprostol Before Hysteroscopy: a Randomized Trial of Different Routes of Administration

Wolfson Medical Center1 site in 1 country120 target enrollmentStarted: July 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Enrollment
120
Locations
1
Primary Endpoint
Preoperative cervical width in centimeters

Study Overview

Brief Summary

This is a randomized trial, assessing Misoprostol efficacy in cervical preparation several hours prior to hysteroscopy, comparing the different routes of administration (PO/PV/buccal). Initial cervical dilatation will be assessed, as well as surgical ease of dilatation, time required to achieve dilatation and patient preference.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Care Provider)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients admitted for elective hysteroscopy (diagnostic/surgical) at Wolfson Medical Center
  • Written consent supplied

Exclusion Criteria

  • Contraindications to prostaglandin treatment (severe asthma, glaucoma, severe cardiac disease, renal failure)
  • Prostaglandin allergy
  • Pregnancy
  • Genital infection
  • Space-occupying lesion in the endocervical canal
  • Prior cervical surgery

Arms & Interventions

PO Misoprostol

Active Comparator

Patients assigned to PO Misoprostol (Cytotec) 400 mg once, 2-4 hours prior to hysteroscopy

Intervention: Misoprostol (Cytotec) (Drug)

PV Misoprostol

Active Comparator

Patients assigned to PV Misoprostol (Cytotec) 400 mg once, 2-4 hours prior to hysteroscopy

Intervention: Misoprostol (Cytotec) (Drug)

Buccal Misoprostol

Active Comparator

Patients assigned to buccal Misoprostol (Cytotec) 400 mg once, 2-4 hours prior to hysteroscopy

Intervention: Misoprostol (Cytotec) (Drug)

Outcomes

Primary Outcomes

Preoperative cervical width in centimeters

Time Frame: intraoperative

Initial cervical dilatation assessed by performing cervical dilatation , beginning with a number 10 Hegar dilator and subsequently inserting smaller Hegar dilators until the dilator can pass through the internal os without resistance. The largest one to pass will consist the initial cervical width.

Secondary Outcomes

  • Time required to achieve cervical dilatation(intraoperative)
  • Surgical complications(intraoperative)
  • Ease of cervical dilatation(intraoperative)
  • Patient preference(baseline)
  • Adverse effects of medication(baseline)

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Hadas Ganer Herman

MD

Wolfson Medical Center

Study Sites (1)

Loading locations...

Similar Trials

Same-day Cervical Preparation With... | Clinical Trial